Sign In
Section Navigation
Common TitlePACTG 1043
Official Title Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission
Phase Phase III
ClinicalTrials.gov NCT00099359
Treatments
Nelfinavir
Nelfinavir Viracept

Nelfinavir

Tradename:ViraceptOther Names:NFVClass:Protease Inhibitors (PI)
Categories PharmacologyPediatricsTreatment-NaiveGeneral Pharmacology
Funding
Non-IndustryEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
References
  • Mirochnick M, Nielsen-Saines K, Pilotto JH, et al. Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life. Pediatr Infect Dis J. 2011;30:769-72.
    [PubMed Abstract]
  • Nielsen-Saines K, Watts DH, Veloso VG, et al. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med. 2012;366:2368-79.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.